Nativita: Key Component
JLLC Nativita, a research and development center, has opened in Belarus (Beshenkovichi, Vitebsk region). The premises of this modern enterprise has been constructed at the place of an old concrete-steel construction shop.
Establishment and development of an R&D center, JLLC Nativita, is a large investment project implemented under support of partnering companies Natko Pharma Limited (India), VitVar LLC (Belarus, Vitebsk), JSC Vita Pharma (Slovakia), AB ZIA valda (Litva). A Russian Biotechnological Company Biocad is a strategic partner of the project.
It is the first and so far the only medico-pharmaceutical cluster in Belarus, opened as an important component of the manufacturing process. It is involved in investigation of biological activity of monoclonal antibodies used for development of biosimilars, it also performs the search and development of new drugs. The research center performs comprehensive product quality control according to the latest methods.
The new site will manufacture biotechnological products based on monoclonal antibodies, and chemical products, first generics. Manufacture of drugs for cancer, autoimmune disorders and severe infections, included into the import substitution program, will begin in 2017.